Effects of Expressive Writing in Breast Cancer Survivors With Lymphedema
OBJECTIVES:
Primary
- To determine if expressive writing improves quality of life (QOL) relative to the
control condition in breast cancer survivors with chronic stage II lymphedema.
- To determine if expressive writing improves physical and psychological
symptoms/outcomes (i.e., fatigue, psychological distress, activity level, confidence in
body) relative to the control condition in breast cancer survivors with chronic
lymphedema.
Secondary
- To explore the influence of individual difference variables (dispositional optimism,
emotional intelligence, and repressive coping) on outcomes associated with this
intervention to include identification of subsets of individuals for whom expressive
writing is most effective.
- To explore the influence of intrusive/avoidant thinking as a mediator between the
intervention and outcomes of QOL and physical and psychological symptoms.
OUTLINE: Patients are randomized to 1 of 2 treatment groups.
Patients travel to the School of Nursing at Vanderbilt University or meet a team member in
their home or another private location for an initial visit. Patients complete
questionnaires, are measured for height and weight data, and arm fluid measurements.
- Expressive writing group: Twenty minutes a day, twice a week for 2 weeks, patients
write about their deepest thoughts and feelings regarding their lymphedema and its
treatment.
- Daily diary group (control): Twenty minutes a day, twice a week for 2 weeks patients
write about how they manage their time .
Patients complete quality-of-life questionnaires periodically.
After completion of study, patients are followed at 1, 3, and 6 months.
Interventional
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Physical and psychological symptoms
6 months
No
Shiela H. Ridner, MSHSA, MSN, PhD, RN
Study Chair
Vanderbilt-Ingram Cancer Center
United States: Federal Government
CDR0000587736
NCT00679185
January 2007
January 2011
Name | Location |
---|---|
Vanderbilt-Ingram Cancer Center | Nashville, Tennessee 37232-6838 |
Vanderbilt-Ingram Cancer Center - Cool Springs | Nashville, Tennessee 37064 |
Vanderbilt-Ingram Cancer Center at Franklin | Nashville, Tennessee 37064 |